Feb 26 (Reuters) - Nanosonics Ltd NAN.AX :
* HALF YEAR REVENUE OF A$79.6 MILLION, DOWN 2%
* CONTINUES TO TARGET SUBMISSION OF FDA DE NOVO APPLICATION
FOR
CORIS BY END OF Q3 FY24
* TOTAL REVENUE IN H2 IS EXPECTED TO GROW BETWEEN 6-15% OVER
H1
* HY GROSS PROFIT MARGIN OF 79.7%, UP FROM 78.9% IN PCP
* EXPECT BOTH UNIT AND REVENUE GROWTH IN H2 OVER H1
* FULL YEAR REVENUE IS EXPECTED TO BE BETWEEN A$164 MILLION
AND
A$171 MILLION
* HY OPERATING PROFIT BEFORE TAX OF A$4.9 MILLION VERSUS
A$11.4
MILLION
Source text for Eikon: ID:nASX4GHsZp
Further company coverage: NAN.AX
((Reuters.Briefs@thomsonreuters.com;))